Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Orthopedic Implants Market, by Product
1.4.2 North America Orthopedic Implants Market, by End-use
1.4.3 North America Orthopedic Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Orthopedic Implants Market by Product
3.1 North America Knee Implants Market by Country
3.2 North America Spinal Implants Market by Country
3.3 North America Craniomaxillofacial Implants Market by Country
3.4 North America Hip Implants Market by Country
3.5 North America Dental Implants Market by Country
3.6 North America SET Implants Market by Country
Chapter 4. North America Orthopedic Implants Market by End-use
4.1 North America Hospitals Market by Country
4.2 North America Orthopedic Clinics Market by Country
4.3 North America Others Market by Country
Chapter 5. North America Orthopedic Implants Market by Country
5.1 US Orthopedic Implants Market
5.1.1 US Orthopedic Implants Market by Product
5.1.2 US Orthopedic Implants Market by End-use
5.2 Canada Orthopedic Implants Market
5.2.1 Canada Orthopedic Implants Market by Product
5.2.2 Canada Orthopedic Implants Market by End-use
5.3 Mexico Orthopedic Implants Market
5.3.1 Mexico Orthopedic Implants Market by Product
5.3.2 Mexico Orthopedic Implants Market by End-use
5.4 Rest of North America Orthopedic Implants Market
5.4.1 Rest of North America Orthopedic Implants Market by Product
5.4.2 Rest of North America Orthopedic Implants Market by End-use
Chapter 6. Company Profiles
6.1 Medtronic PLC
6.1.1 Company overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expenses
6.1.5 SWOT Analysis
6.2 Johnson & Johnson (DePuy Synthes)
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental &Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.2.5.2 Acquisition and Mergers:
6.3 Stryker Corporation
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Product Launches and Product Expansions:
6.3.5.2 Acquisition and Mergers:
6.4 Zimmer Biomet Holdings, Inc.
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.5 Smith & Nephew PLC
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional and Segmental Analysis
6.5.4 Research & Development Expense
6.6 ConMed Corporation
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Regional Analysis
6.6.4 Research & Development Expense
6.7 B. Braun Melsungen AG (Aesculap, Inc.)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Segmental and Regional Analysis
6.7.4 Research & Development Expenses
6.8 Colfax Corporation
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expenses
6.9 NuVasive, Inc.
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.10. Arthrex, Inc.
6.10.1 Company Overview